Mariana Socal, MD, PhD teaches courses on U.S. Pharmaceutical Policy and the U.S. Healthcare System at the Bloomberg School of Public Health. Dr. Socal is a physician trained in adult neurology. Her research focuses on improving pharmaceutical access and affordability. Specific topics include understanding biosimilar adoption, improving FDA regulation for follow-on products, and reducing spending on drugs that cost significantly more but have comparable clinical profiles to their competitors.
Dr. Socal has testified before the U.S. Congress on drug pricing and the provisions established in Build Back Better and H.R.3. Dr. Socal also testified at the Food and Drug Administration on issues related to biopharmaceutical regulation, including insulins. Dr. Socal has advised several state initiatives to reduce drug spending, such as the California Generic Drugs Initiative.
Dr. Socal She holds a Master’s in Public Policy from Princeton University and a PhD in Public Health/Health Systems from Johns Hopkins University.